Helping innovative life science companies grow.Asymmetry Group embodies the notion that asymmetric insights, not benchmarks to the average, should serve as the foundation for robust business decisions. It delivers on this belief by offering advisory services to innovative biopharmaceutical and life sciences clients. Current client offerings include corporate, business unit and product strategy; launch planning; marketing and sales operations; and capability development.

Reporting to the Chief Commercial Officer from August 2016, led multiple functions including all Strategic Insights & Analytics functions (Market Research, Competitive Intelligence, Forecasting), Commercial Information Management, Sales Force Effectiveness, Marketing Excellence, Integrated Product Planning, and Corporate Meetings & Congresses.

Selected as Chief of Staff to EVP, Global Commercial at Biogen, and member of Global Commercial Operations leadership team. Drove efficient and effective conversations on strategic and operational topics/decisions within the Global Commercial Operations leadership team. Led special projects within Commercial and across other functions, including deep focus on market access and pricing. Represented the Commercial organization in various forums. Prepared Board of Director presentations.

Hired, led and developed multi-level international team of ~18, based in US and multiple European countries. Promoted from Director to Senior Director.Created and rolled out multiple new functions designed to enhance capabilities and execution across the Global Commercial organization, including:- Marketing Excellence / Marketing Innovation: developed and implemented a new marketing and cross-functional product planning approach (global / regional / affiliate). Instituted a new approach to incremental and transformative innovation. Codified marketing best practices.- Global Launch Excellence: developing an enduring capability to launch new therapeutic products efficiently and effectively, including a technological solution to globally-coordinate launches;- Global Commercial Digital Technology: develop a center of excellence for digital marketing to enhance utilization and execution of digital technologies globally;- European Digital Technology Innovation Center: started-up a Stockholm-based innovation center to rapidly innovate and prototype non-healthcare based technologies for potential application to Biogen products. - Patient Insights/Centricity: initiated new function to coordinate and improve organization's ability to act on cross-functional insights early in the product development cycle through to mature assets.

Advising life science firms on business plans and growth strategies.

Recruited to: manage the corporate strategic agenda; identify, evaluate and create opportunities for international growth, profitability and development of LIFE's businesses; and lead multiple projects focused on high priority issues and opportunities, working with multidisciplinary project teams.Actively focused on: Corporate strategy & development; M&A; business development; strategic marketing; innovation; business incubation; financial / P&L analysis & modeling; team leadership; employee mentorship & development.

Growth strategy consultant to global pharmaceutical, biotechnology, medical device and diagnostics clients. Developed and pursued business opportunities independently and with other Monitor partners. Oversaw multiple projects teams simultaneously. Co-developed Monitor's new product commercialization practice area. Speaker on topics related to strategic marketing and new product launch. Mentored and developed consultants.__________________________________Specialized in: corporate strategy; strategic marketing; new product launch & commercialization; business development.

Created and implemented new 5-year strategic planning approach for BioPharma Operations. Led cross-functional VP-level plan to inform BioPharma Business Unit 3-year strategic plan. ___________________________________BioPharma operations; strategic planning process development; cross-functional team leadership.

Summer internship with Neurocrine's Business Development group. Researched and recommended structure and terms for a major Phase 3 product licensing agreement; Screened 2500 pain-related compounds for in-licensing potential; Evaluated international biotech companies for potential licensing and acquisition candidates.

(ISO Healthcare Group was acquired by Monitor Group in 2004.)Boutique, life-science focused growth strategy consulting firm. Worked exclusively with pharmaceutical, biotechnology and medical device clients in the U.S. and Europe. Selected by CEO to relocate to London to lead European-based assignments and help integrate practices of a recently-acquired consulting firm with offices in London and Paris.